COMPLETED trials
Read more about the completed trials that MedVadis Research is involved with. Contact us anytime if you would like to volunteer or have any questions.
Adult Migraine
Study ID 235
A Phase 2/3 Open-label, Long-Term, Safety Trial of BHV3500 (zavegepant) Intranasal (IN) for the Acute Treatment of Migraine
Medical Conditions:
Related Conditions:
Sex/Gender:
Age:
Study Completed!
Study ID 240
Phase 3: Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV- 3500 (zavegepant) Intranasal (IN) for the Acute Treatment of Migraine
Medical Conditions:
Adult Migraine
Related Conditions: Adult Migraine
Sex/Gender:
Age:
Study Completed!
Study ID 245
An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Medical Conditions:
Migraine
Related Conditions: Migraine
Sex/Gender:
Age:
Study Completed!
Study ID 250
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2 Study of ABP-450 (prabotulinumtoxinA) Purified Neurotoxin Complex for the Prevention of Migraine Headache
Medical Conditions:
Adult Migraine
Related Conditions: Adult Migraine
Sex/Gender:
Age:
Study Completed!
Study ID 251
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention
Medical Conditions:
Adult Migraine
Related Conditions: Adult Migraine
Sex/Gender:
Age:
Study Completed!
Study ID 261
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Medical Conditions:
Adult Migraine
Related Conditions: Adult Migraine
Sex/Gender:
Age:
Study Completed!
Study ID 285
A Randomized, Multicenter, Dose-Blinded, Phase 2 Extension Study of ABP-450 (prabotulinumtoxinA) Purified Neurotoxin Complex for the Prevention of Migraine Headache
Medical Conditions:
Related Conditions:
Sex/Gender:
Age:
Study Completed!
ALS
No Results Found.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Alzheimer’s Disease
Study ID 258
A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease
Medical Conditions:
Alzheimer's Disease
Related Conditions: Alzheimer's Disease
Sex/Gender:
Age:
Study Completed!
Study ID 263
A Phase 3, Randomized, Double-Blind Placebo-Controlled Parallel-Group 76-Week Study Evaluating The Safety And Efficacy Of Two Doses Of Simufilam In Subjects With Mild-To-Moderate Alzheimer's Disease
Medical Conditions:
Alzheimer's Disease
Related Conditions: Alzheimer's Disease
Sex/Gender:
Age:
Study Completed!
Study ID 277
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study of Buntanetap in Participants with Mild to Moderate Alzheimer’s Disease
Medical Conditions:
Alzheimer's Disease
Related Conditions: Alzheimer's Disease
Sex/Gender:
Age:
Study Completed!
Chronic Knee Pain
Study ID 237
Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Osteoarthritis
Medical Conditions:
Chronic Knee Pain
Related Conditions: Chronic Knee Pain
Sex/Gender:
Age:
Enrollment Complete.
Study ID 246
Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Osteoarthritis
Medical Conditions:
Chronic Knee Pain
Related Conditions: Chronic Knee Pain
Sex/Gender:
Age:
Enrollment Complete.
Study ID 254
Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis
Medical Conditions:
Chronic Knee Pain
Related Conditions: Chronic Knee Pain
Sex/Gender:
Age:
Enrollment Complete.
Chronic Low Back Pain
Study ID 238
Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Chronic Low Back Pain
Medical Conditions:
Chronic Back Pain
Related Conditions: Chronic Back Pain
Sex/Gender:
Age:
Study Completed!
Study ID 247
Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Chronic Low Back Pain
Medical Conditions:
Chronic Back Pain
Related Conditions: Chronic Back Pain
Sex/Gender:
Age:
Study Completed!
Study ID 255
Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Chronic Low Back Pain
Medical Conditions:
Chronic Back Pain
Related Conditions: Chronic Back Pain
Sex/Gender:
Age:
Study Completed!
Study ID 271
A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Chronic Low Back Pain
Medical Conditions:
Chronic Back Pain
Related Conditions: Chronic Back Pain
Sex/Gender:
Age:
Study Completed!
Diabetic Neuropathy
Study ID 239
Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain
Medical Conditions:
Diabetic Neuropathy
Related Conditions: Diabetic Neuropathy
Sex/Gender:
Age:
Study Completed!
Study ID 248
Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain
Medical Conditions:
Diabetic Neuropathy
Related Conditions: Diabetic Neuropathy
Sex/Gender:
Age:
Study Completed!
Study ID 256
Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Pain
Medical Conditions:
Diabetic Neuropathy
Related Conditions: Diabetic Neuropathy
Sex/Gender:
Age:
Study Completed!
Study ID 260
A Phase 2, Randomized, Double-blind, Active-controlled, Dose-ranging, Parallel-design Study of the Efficacy and Safety of VX-548 in Subjects With Painful Diabetic Peripheral Neuropathy
Medical Conditions:
Diabetic Neuropathy
Related Conditions: Diabetic Neuropathy
Sex/Gender:
Age:
Study Completed!
Study ID 268
A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain (NEPTUNE-17)
Medical Conditions:
Diabetic Neuropathy
Related Conditions: Diabetic Neuropathy
Sex/Gender:
Age:
Study Completed!
Study ID 272
A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain
Medical Conditions:
Diabetic Neuropathy
Related Conditions: Diabetic Neuropathy
Sex/Gender:
Age:
Study Completed!
Study ID 286
A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to Evaluate LY3556050 in Adult Participants with Diabetic Peripheral Neuropathic Pain
Medical Conditions:
Diabetic Neuropathy
Related Conditions: Diabetic Neuropathy
Sex/Gender:
Age:
Study Completed!
Obesity
No Results Found.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Pediatric Migraine
Study ID 224
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy, Safety, and Tolerability of Subcutaneous Administration of Fremanezumab Versus Placebo for the Preventive Treatment of Chronic Migraine in Pediatric Patients 6 to 17 Years of Age
Medical Conditions:
Pediatric Migraine
Related Conditions: Pediatric Migraine
Sex/Gender:
Age:
Study Completed!
Study ID 225
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy, Safety, and Tolerability of Subcutaneous Administration of Fremanezumab Versus Placebo for the Preventive Treatment of Episodic Migraine in Pediatric Patients 6 to 17 Years of Age
Medical Conditions:
Pediatric Migraine
Related Conditions: Pediatric Migraine
Sex/Gender:
Age:
Study Completed!
Study ID 226
A Multicenter, Open-Label Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Monthly Subcutaneous Administration of Fremanezumab for the Preventive Treatment of Episodic and Chronic Migraine in Pediatric Patients 6 to 17 Years of Age
Medical Conditions:
Pediatric Migraine
Related Conditions: Pediatric Migraine
Sex/Gender:
Age:
Study Completed!
Study ID 241
A Randomized, Double-Blind, Placebo-Controlled Study Of Lasmiditan For Acute Treatment Of Migraine In Children Aged 6 to 17
Medical Conditions:
Pediatric Migraine
Related Conditions: Pediatric Migraine
Sex/Gender:
Age:
Study Completed!
Study ID 242
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Children Aged 6 to 17 with Migraine
Medical Conditions:
Pediatric Migraine
Related Conditions: Pediatric Migraine
Sex/Gender:
Age:
Study Completed!
Study ID 249
Phase 3, multicenter, randomized, double-blind, group sequential, placebo-controlled study to assess efficacy and safety of rimegepant for the treatment of migraine (with or without aura) in children and adolescents ≥ 6 to < 18 years of age
Medical Conditions:
Pediatric Migraine
Related Conditions: Pediatric Migraine
Sex/Gender:
Age:
Study Completed!
Study ID 253
Phase 3, multicenter, open-label study to assess the long-term safety and tolerability of rimegepant for the acute treatment of migraine (with or without aura) in children and adolescents ≥ 6 to < 18 years of age
Medical Conditions:
Pediatric Migraine
Related Conditions: Pediatric Migraine
Sex/Gender:
Age:
Study Completed!